K-C Suspension Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with K-C Suspension
G
- G-Tuss (guaifenesin / hydrocodone)
- Gani-Tuss NR (codeine / guaifenesin)
- gatifloxacin
- gemifloxacin
- Gengraf (cyclosporine)
- Gentex HC (guaifenesin / hydrocodone / phenylephrine)
- Genvoya (cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide)
- Gestuss-HC (diphenhydramine / hydrocodone / phenylephrine)
- Giltuss Ped-C (codeine / guaifenesin / phenylephrine)
- Glydeine (codeine / guaifenesin)
- grepafloxacin
- Gua HC (guaifenesin / hydrocodone)
- Gua PC (codeine / guaifenesin / pseudoephedrine)
- Guai-Co (codeine / guaifenesin)
- Guaiatussin AC (codeine / guaifenesin)
- Guaiatussin DAC (codeine / guaifenesin / pseudoephedrine)
- Guaifen AC (codeine / guaifenesin)
- Guaifen DAC (codeine / guaifenesin / pseudoephedrine)
- Guaifen-C (codeine / guaifenesin)
- Guaifenesin AC (codeine / guaifenesin)
- Guaifenesin DAC (codeine / guaifenesin / pseudoephedrine)
- guaifenesin / hydrocodone
- guaifenesin / hydrocodone / pheniramine / phenylephrine / phenylpropanolamine
- guaifenesin / hydrocodone / pheniramine / phenylpropanolamine / pyrilamine
- guaifenesin / hydrocodone / phenylephrine
- guaifenesin / hydrocodone / pseudoephedrine
- guaifenesin / hydromorphone
- Guaitussin AC (codeine / guaifenesin)
- Guiaphen HD (chlorpheniramine / hydrocodone / phenylephrine)
- Guiaplex HC (guaifenesin / hydrocodone / phenylephrine)
- Guiatuss AC (codeine / guaifenesin)
- Guiatuss DAC (codeine / guaifenesin / pseudoephedrine)
- Guiatussin DAC (codeine / guaifenesin / pseudoephedrine)
- Guiatussin with Codeine (codeine / guaifenesin)
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.